United States-based Ebb Therapeutics is launching a wearable sleep device with proprietary technology that targets the root cause of sleeplessness, a racing, or overactive mind at the 2020 CES, it was reported on Saturday.
The device is to arrive on the consumer market after several years of research and fundraising
The company says that it is the first and only sleep solution that uses precise cooling, called PrecisionCool Technology, to decrease metabolic activity in the frontal cortex. A scientifically-engineered, fluid-filled headband softly wraps around the head and cools the forehead using an intelligent cooling algorithm in order to maintain an optimal temperature range over the course of the night. As brain activity declines, the mind calms and the user is able to fall into a deeper, more restorative sleep.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon